Adma Biologics(ADMA.US)

Last Updated 19:00:00 ET
longbridge loading

17:28 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
-0.81%
prnewswire·
US
ADMA
-0.81%

20:15 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

prnewswire·
US
ADMA
-0.81%
US
VHT
+0.27%
US
XLV
-0.13%
prnewswire·
US
ADMA
-0.81%
US
VHT
+0.27%
US
XLV
-0.13%

A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations

Simplywall·
US
ADMA
-0.81%
US
IBB
+2.27%
US
SBIO
+3.75%
Simplywall·
US
ADMA
-0.81%
US
IBB
+2.27%
US
SBIO
+3.75%

Innovent to Present Multiple Clinical and Preclinical Results of Mazdutide and Next-Generation Obesity & Metabolic Pipeline at the 2026 ADA Scientific Sessions

Unusual Whales·
SZ
159892
-0.71%
SH
589720
+1.03%
SZ
159615
-0.30%
Unusual Whales·
SZ
159892
-0.71%
SH
589720
+1.03%
SZ
159615
-0.30%

17:24 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
-0.81%
US
IBBQ
+2.43%
US
FBT
+2.14%
prnewswire·
US
ADMA
-0.81%
US
IBBQ
+2.43%
US
FBT
+2.14%

03:18 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
-0.81%
US
XBI
+3.88%
US
BBH
+0.96%
prnewswire·
US
ADMA
-0.81%
US
XBI
+3.88%
US
BBH
+0.96%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
TRDA
+6.90%
US
AGL
-8.23%
US
ATRA
+0.43%
benzinga_article·
US
TRDA
+6.90%
US
AGL
-8.23%
US
ATRA
+0.43%

Adma Biologics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 114.49 M

Earnings Watch·
US
ADMA
-0.81%
Earnings Watch·
US
ADMA
-0.81%

ADMA (ADMA) Q1 2026 Earnings Transcript

nasdaq·
US
ADMA
-0.81%
US
XBI
+3.88%
US
IBBQ
+2.43%
nasdaq·
US
ADMA
-0.81%
US
XBI
+3.88%
US
IBBQ
+2.43%

ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY26 sales guidance below estimates.

benzinga_article·
US
ADMA
-0.81%
benzinga_article·
US
ADMA
-0.81%
© 2026 Longbridge｜Disclaimer